Benzinga··PrnewswireCo-Diagnostics Reports Sharp Revenue Decline, $46.9M Loss as Cash Reserves Dwindle
Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.
CODXfinancial resultscommercialization